Cargando…

Angiotensin‐(1–7) protects cardiomyocytes against high glucose‐induced injuries through inhibiting reactive oxygen species‐activated leptin–p38 mitogen‐activated protein kinase/extracellular signal‐regulated protein kinase 1/2 pathways, but not the leptin–c‐Jun N‐terminal kinase pathway in vitro

AIMS/INTRODUCTION: Angiotensin‐(1–7) (Ang‐[1–7]), recognized as a new bioactive peptide in the renin–angiotensin system, shows biological and pharmacological properties in diabetic cardiovascular diseases. The leptin‐induced p38 mitogen‐activated protein kinase (MAPK) pathway has been reported to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Yiyan, Xu, Qing, Zeng, Bo, Zhang, Wei, Zhen, Yulan, Zhai, Yuansheng, Cheng, Fei, Mei, Weiyi, Zheng, Dongdan, Feng, Jianqiang, Lan, Jun, Chen, Jingfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497033/
https://www.ncbi.nlm.nih.gov/pubmed/27896943
http://dx.doi.org/10.1111/jdi.12603
_version_ 1783248088103649280
author Lei, Yiyan
Xu, Qing
Zeng, Bo
Zhang, Wei
Zhen, Yulan
Zhai, Yuansheng
Cheng, Fei
Mei, Weiyi
Zheng, Dongdan
Feng, Jianqiang
Lan, Jun
Chen, Jingfu
author_facet Lei, Yiyan
Xu, Qing
Zeng, Bo
Zhang, Wei
Zhen, Yulan
Zhai, Yuansheng
Cheng, Fei
Mei, Weiyi
Zheng, Dongdan
Feng, Jianqiang
Lan, Jun
Chen, Jingfu
author_sort Lei, Yiyan
collection PubMed
description AIMS/INTRODUCTION: Angiotensin‐(1–7) (Ang‐[1–7]), recognized as a new bioactive peptide in the renin–angiotensin system, shows biological and pharmacological properties in diabetic cardiovascular diseases. The leptin‐induced p38 mitogen‐activated protein kinase (MAPK) pathway has been reported to contribute to high glucose (HG)‐induced injury. In the present study, we showed the mechanism of how Ang‐(1–7) can protect against HG‐stimulated injuries in H9c2 cells. MATERIALS AND METHODS: H9c2 cells were treated with 35 mmol/L glucose (HG) for 24 h to establish a model of HG‐induced damage. Apoptotic cells were observed by Hoechst 33258 staining. Cell viability was analyzed by cell counter kit‐8. The expression of protein was detected by western blot. Reactive oxygen species was tested by 2′,7′‐dichlorodihydrofluorescein diacetate staining. Mitochondrial membrane potential was measured by 5,5′,6,6′‐Tetrachloro‐1,1′,3,3′‐tetraethyl‐imidacarbocyanine iodide staining. RESULTS: The present results showed that treating H9c2 cells with HG obviously enhanced the expressions of both the leptin and phosphorylated (p)‐MAPK pathway. However, the overexpression levels of leptin and p‐p38 MAPK/p‐extracellular signal‐regulated protein kinase 1/2 (ERK1/2), but not p‐c‐Jun N‐terminal kinase, were significantly suppressed by treatment of the cells with Ang‐(1–7). Additionally, leptin antagonist also markedly suppressed the overexpressions of p38 and ERK1/2 induced by HG, whereas leptin antagonist had no influence on the overexpression of c‐Jun N‐terminal kinase. More remarkable, Ang‐(1–7), leptin antagonist, SB203580 or SP600125, respectively, significantly inhibited the injuries induced by HG, such as the increased cell viability, decreased apoptotic rate, reduction of ROS production and increased mitochondrial membrane potential. Furthermore, the overexpressions of p38 MAPK, ERK1/2 and leptin were suppressed by N‐actyl‐L‐cystine. CONCLUSIONS: The present findings show that Ang‐(1–7) protects from HG‐stimulated damage as an inhibitor of the reactive oxygen species–leptin–p38 MAPK/ERK1/2 pathways, but not the leptin–c‐Jun N‐terminal kinase pathway in vitro.
format Online
Article
Text
id pubmed-5497033
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54970332017-07-14 Angiotensin‐(1–7) protects cardiomyocytes against high glucose‐induced injuries through inhibiting reactive oxygen species‐activated leptin–p38 mitogen‐activated protein kinase/extracellular signal‐regulated protein kinase 1/2 pathways, but not the leptin–c‐Jun N‐terminal kinase pathway in vitro Lei, Yiyan Xu, Qing Zeng, Bo Zhang, Wei Zhen, Yulan Zhai, Yuansheng Cheng, Fei Mei, Weiyi Zheng, Dongdan Feng, Jianqiang Lan, Jun Chen, Jingfu J Diabetes Investig Articles AIMS/INTRODUCTION: Angiotensin‐(1–7) (Ang‐[1–7]), recognized as a new bioactive peptide in the renin–angiotensin system, shows biological and pharmacological properties in diabetic cardiovascular diseases. The leptin‐induced p38 mitogen‐activated protein kinase (MAPK) pathway has been reported to contribute to high glucose (HG)‐induced injury. In the present study, we showed the mechanism of how Ang‐(1–7) can protect against HG‐stimulated injuries in H9c2 cells. MATERIALS AND METHODS: H9c2 cells were treated with 35 mmol/L glucose (HG) for 24 h to establish a model of HG‐induced damage. Apoptotic cells were observed by Hoechst 33258 staining. Cell viability was analyzed by cell counter kit‐8. The expression of protein was detected by western blot. Reactive oxygen species was tested by 2′,7′‐dichlorodihydrofluorescein diacetate staining. Mitochondrial membrane potential was measured by 5,5′,6,6′‐Tetrachloro‐1,1′,3,3′‐tetraethyl‐imidacarbocyanine iodide staining. RESULTS: The present results showed that treating H9c2 cells with HG obviously enhanced the expressions of both the leptin and phosphorylated (p)‐MAPK pathway. However, the overexpression levels of leptin and p‐p38 MAPK/p‐extracellular signal‐regulated protein kinase 1/2 (ERK1/2), but not p‐c‐Jun N‐terminal kinase, were significantly suppressed by treatment of the cells with Ang‐(1–7). Additionally, leptin antagonist also markedly suppressed the overexpressions of p38 and ERK1/2 induced by HG, whereas leptin antagonist had no influence on the overexpression of c‐Jun N‐terminal kinase. More remarkable, Ang‐(1–7), leptin antagonist, SB203580 or SP600125, respectively, significantly inhibited the injuries induced by HG, such as the increased cell viability, decreased apoptotic rate, reduction of ROS production and increased mitochondrial membrane potential. Furthermore, the overexpressions of p38 MAPK, ERK1/2 and leptin were suppressed by N‐actyl‐L‐cystine. CONCLUSIONS: The present findings show that Ang‐(1–7) protects from HG‐stimulated damage as an inhibitor of the reactive oxygen species–leptin–p38 MAPK/ERK1/2 pathways, but not the leptin–c‐Jun N‐terminal kinase pathway in vitro. John Wiley and Sons Inc. 2017-02-28 2017-07 /pmc/articles/PMC5497033/ /pubmed/27896943 http://dx.doi.org/10.1111/jdi.12603 Text en © 2016 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Articles
Lei, Yiyan
Xu, Qing
Zeng, Bo
Zhang, Wei
Zhen, Yulan
Zhai, Yuansheng
Cheng, Fei
Mei, Weiyi
Zheng, Dongdan
Feng, Jianqiang
Lan, Jun
Chen, Jingfu
Angiotensin‐(1–7) protects cardiomyocytes against high glucose‐induced injuries through inhibiting reactive oxygen species‐activated leptin–p38 mitogen‐activated protein kinase/extracellular signal‐regulated protein kinase 1/2 pathways, but not the leptin–c‐Jun N‐terminal kinase pathway in vitro
title Angiotensin‐(1–7) protects cardiomyocytes against high glucose‐induced injuries through inhibiting reactive oxygen species‐activated leptin–p38 mitogen‐activated protein kinase/extracellular signal‐regulated protein kinase 1/2 pathways, but not the leptin–c‐Jun N‐terminal kinase pathway in vitro
title_full Angiotensin‐(1–7) protects cardiomyocytes against high glucose‐induced injuries through inhibiting reactive oxygen species‐activated leptin–p38 mitogen‐activated protein kinase/extracellular signal‐regulated protein kinase 1/2 pathways, but not the leptin–c‐Jun N‐terminal kinase pathway in vitro
title_fullStr Angiotensin‐(1–7) protects cardiomyocytes against high glucose‐induced injuries through inhibiting reactive oxygen species‐activated leptin–p38 mitogen‐activated protein kinase/extracellular signal‐regulated protein kinase 1/2 pathways, but not the leptin–c‐Jun N‐terminal kinase pathway in vitro
title_full_unstemmed Angiotensin‐(1–7) protects cardiomyocytes against high glucose‐induced injuries through inhibiting reactive oxygen species‐activated leptin–p38 mitogen‐activated protein kinase/extracellular signal‐regulated protein kinase 1/2 pathways, but not the leptin–c‐Jun N‐terminal kinase pathway in vitro
title_short Angiotensin‐(1–7) protects cardiomyocytes against high glucose‐induced injuries through inhibiting reactive oxygen species‐activated leptin–p38 mitogen‐activated protein kinase/extracellular signal‐regulated protein kinase 1/2 pathways, but not the leptin–c‐Jun N‐terminal kinase pathway in vitro
title_sort angiotensin‐(1–7) protects cardiomyocytes against high glucose‐induced injuries through inhibiting reactive oxygen species‐activated leptin–p38 mitogen‐activated protein kinase/extracellular signal‐regulated protein kinase 1/2 pathways, but not the leptin–c‐jun n‐terminal kinase pathway in vitro
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497033/
https://www.ncbi.nlm.nih.gov/pubmed/27896943
http://dx.doi.org/10.1111/jdi.12603
work_keys_str_mv AT leiyiyan angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro
AT xuqing angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro
AT zengbo angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro
AT zhangwei angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro
AT zhenyulan angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro
AT zhaiyuansheng angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro
AT chengfei angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro
AT meiweiyi angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro
AT zhengdongdan angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro
AT fengjianqiang angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro
AT lanjun angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro
AT chenjingfu angiotensin17protectscardiomyocytesagainsthighglucoseinducedinjuriesthroughinhibitingreactiveoxygenspeciesactivatedleptinp38mitogenactivatedproteinkinaseextracellularsignalregulatedproteinkinase12pathwaysbutnottheleptincjunnterminalkinasepathwayinvitro